Quisinostat is a pan-histone deacetylase (HDAC) inhibitor compound. It is a member of the methylindole class and is characterized as a hydroxamic acid.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 875320-29-9
Quisinostat dihydrochloride
pharmaceutical raw material
Givinostat
pharmaceutical raw material
Anacetrapib
pharmaceutical raw material
Growth hormone releasing hexapeptide
pharmaceutical raw material
Atenolol impurity D
pharmaceutical raw material
Trandolapril
pharmaceutical raw material
N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide
PAWIYAYFNXQGAP-UHFFFAOYSA-N
CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO